Robeco Institutional Asset Management B.V. Biogen Inc. Transaction History
Robeco Institutional Asset Management B.V.
- $66.7 Billion
- Q3 2025
A detailed history of Robeco Institutional Asset Management B.V. transactions in Biogen Inc. stock. As of the latest transaction made, Robeco Institutional Asset Management B.V. holds 671,054 shares of BIIB stock, worth $100 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
671,054
Previous 448,757
49.54%
Holding current value
$100 Million
Previous $56.4 Million
66.79%
% of portfolio
0.14%
Previous 0.09%
Shares
52 transactions
Others Institutions Holding BIIB
# of Institutions
1,045Shares Held
132MCall Options Held
2.84MPut Options Held
2.54M-
Vanguard Group Inc Valley Forge, PA17.3MShares$2.58 Billion0.04% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$2.36 Billion1.62% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.17 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.47MShares$1.12 Billion0.04% of portfolio
-
Wellington Management Group LLP Boston, MA4.8MShares$717 Million0.11% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $21.5B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...